Those multiple enzyme regulation mechanism is thus expected to more thoroughly suppress the neutral lipid biosynthesis than simply inhibiting ACC1 and better circumvent the hyperlipidemia caused by ACC1 inhibition. The gene discussed is ACACA; the disease is hyperlipidemia.